PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 33243092-0 2020 Effect of CYP3A5*3 genotypes on lumefantrine plasma concentrations among malaria-HIV-infected women. Lumefantrine 32-44 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 10-16 33243092-1 2020 Aim: We aimed to assess the effect of a functional polymorphism of CYP3A5 on lumefantrine pharmacokinetics. Lumefantrine 77-89 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 67-73 33243092-8 2020 Conclusion: CYP3A5*3 genetic variant is associated with a high maximum plasma concentration of lumefantrine. Lumefantrine 95-107 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 12-18 31744845-0 2019 Pregnancy and CYP3A5 Genotype Affect Day 7 Plasma Lumefantrine Concentrations. Lumefantrine 50-62 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 14-20 31744845-13 2019 SIGNIFICANCE STATEMENT: This study reports a number of factors contributing to the lower day 7 lumefantrine (LF) concentration in women, which includes pregnancy, body weight, and CYP3A5*1/*1 genotype. Lumefantrine 95-107 cytochrome P450 family 3 subfamily A member 5 Homo sapiens 180-186